Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the Clinic-Reference-Cited by-同舟云学术

Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the Clinic

Published:2019-04-06 Issue:4 Volume:11 Page:490
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Angelucci Adriano^ORCID

Abstract

The 21st century has finally seen the full achievement of targeted therapy to treat cancer with the promise of lower side effects and improved efficacy with respect to cytotoxic chemotherapeutics [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/11/4/490/pdf

Reference11 articles.

1. DrugBank: a comprehensive resource for in silico drug discovery and exploration

2. Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response

3. Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bosutinib Stimulates Macrophage Survival, Phagocytosis, and Intracellular Killing of Bacteria;ACS Infectious Diseases;2024-04-11

2. Comprehensive in silico discovery of c-Src tyrosine kinase inhibitors in cancer treatment: A unified approach combining pharmacophore modeling, 3D QSAR, DFT, and molecular dynamics simulation;Journal of King Saud University - Science;2024-03

3. Bosutinib stimulates macrophage survival, phagocytosis and intracellular killing of bacteria;2023-12-14

4. Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures;Pharmaceutics;2023-01-21

5. SRC kinase-mediated signaling pathways and targeted therapies in breast cancer;Breast Cancer Research;2022-12-29